Michael C Milone

9PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringMolecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 05, 2026
Rab5 improves CAR T cell efficacy via reducing fratricide and maintaining surface CAR levels.

|Apr 17, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptor.

|Nov 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.

Alfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya

|Aug 26, 2022
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma.

Kavita M Dhodapkar, Adam D Cohen, Akhilesh Kaushal

|May 31, 2022
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors.

Hongru Zhang, Pengfei Yu, Vivek S Tomar

|Feb 22, 2022
Rapid manufacturing of non-activated potent CAR T cells.

Saba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz

Pageof 2

Frequent Collaborators

4 joint publications

Carl H June

3 joint publications

Alfred L Garfall

3 joint publications

Adam D Cohen

2 joint publications

Simon F Lacey